A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
During this company webcast, we welcome Jaguar Health, ticker symbol of JAGX on the NASDAQ, and joining us from the company is Lisa Conte, the company’s Chief Executive Officer. Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing...
During this company webcast, we welcome Cadrenal Therapeutics, ticker symbol of CVKD on the Nasdaq. And joining us today from the company is Quang Pham. Quang is the Founder, Chairman and CEO of Cadrenal. Cadrenal Therapeutics is developing tecarfarin for unmet needs...
During this presentation, we welcome Shuttle Pharmaceuticals. Shuttle is traded on the Nasdaq under the symbol SHPH. And joining us today from the company is Dr. Anatoly Dritschilo, the company's Chairman and CEO. Founded in 2012 by faculty members of the Georgetown...
During this presentation, we welcome Precision Optics, ticker symbol of POCI on the Nasdaq. And joining us from the company is the company’s CEO, Dr. Joe Forkey. Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on...
For this fireside chat, we welcome Dyadic, Inc., which trades on the NASDAQ under the ticker DYAI. Joining us from the company is Mark Emalfarb, Chief Executive Officer. Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company focused on building...
In this presentation, we welcome Scientific Industries, Inc. ticker symbol is SCND on the OTC. Presenting from the company today are John Moore, Chairman and Helena Santos, Chief Executive Officer. Scientific Industries (OTCQB:SCND), is a life science tool provider....
During this presentation and webcast, we welcome Kiora Pharmaceuticals, ticker symbol of KPRX on the NASDAQ. And joining us today from the company is Brian Strem. Brian is the company’s Chief Executive Officer, and we also have Melissa Tosca, the company’s EVP of...
During this company webcast, we welcome Syra Health, ticker symbol SYRA on the NASDAQ. Joining us today from the company is Dr. Deepika Vuppalanchi, Chief Executive Officer. Syra Health is a healthcare technology company addressing some of healthcare's most...
In this discussion, we welcome Aytu BioPharma, NASDAQ ticker symbol AYTU. And with us today is their Chief Executive Officer, Josh Disbrow. Aytu is a pharmaceutical company focused on commercializing novel therapeutics. This Fireside Chat was recorded during the...
During this presentation, we welcome NeurAxis, ticker symbol NRXS on the NYSE American. Joining us today from the company is Brian Carrico, Chief Executive Officer. NeurAxis, Inc., is a medical technology company focused on neuromodulation therapies to address chronic...
During this fireside chat we welcome Reliq Health Technologies ticker symbol of RHT on the Toronto Venture Exchange and RQHTF in the United States. Joining me from the company today is its Chief Executive Officer, Chris Shields. Reliq Health Technologies is a growing...
We are extremely pleased to invite Larry Heaton, Chief Executive Officer of Zomedica, ticker symbol of ZOM on the NYSE American to join us here this morning for a presentation. Based in Ann Arbor, Michigan, Zomedica is a veterinary health company creating products for...
NEW YORK - Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr. Bridget Martell to the Company's...
PONTE VEDRA, Fla., May 23, 2024 /PRNewswire/ -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes and deaths...
DENVER, CO / May 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, CEO, will participate in a webcasted fireside chat and host one-on-one...
GARDNER, Mass., May 23, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that Dr. Joe Forkey, Chief Executive Officer, will...
CARMEL, Ind., May 22, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the...
CARMEL, Ind., May 21, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will participate in a...
CARMEL, Ind., May 16, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced the...
Conference call begins at 10:00 a.m. Eastern time on Thursday, May 16, 2024 WOBURN, MA / ACCESSWIRE / May 15, 2024 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today...
353% Revenue Growth with improvement in Adjusted EBITDASARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide...
CARMEL, Ind., May 15, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report summarized...
Conference Call Scheduled for today, May 15, 2024, at 5:00pm ETGARDNER, Mass., May 15, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced...
Q3 2024 ADHD Portfolio net revenue up 49% compared to Q3 2023Q3 2024 adjusted EBITDA 1 improved by $7.0 million compared to Q3 2023TTM March 2024 operating income of $7.3 million for the Rx BusinessTTM March 2024 companywide adjusted EBITDA of positive $15.4...
Human Health Sector Final Clinical Study Report has been issued for the First-In-Human Phase 1 clinical trial demonstrating safety and antibody response for DYAI-100, a recombinant protein receptor binding domain booster vaccine candidate for protection against...
PORTLAND, Maine, May 14, 2024 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
Conference Call Today at 8:30 am Eastern Time QUEENSBURY, N.Y., May 14, 2024 -- Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today...
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 13, 2024 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves...
CARLSBAD, Calif. , May 13, 2024 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has scheduled a conference call...
PONTE VEDRA, Fla., May 9, 2024 /PRNewswire/ -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes and deaths...
GARDNER, Mass., May 09, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced a $9 million production order from a leading surgical company...
DENVER, CO / May 8, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its financial and operational results for its third quarter of fiscal 2024 for the period ended...
GARDNER, Mass., May 08, 2024 -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that it has scheduled a conference call to...
Conference Call Scheduled for Wednesday, May 15, 2024 at 9:00 AM ETPORTLAND, Maine, May 08, 2024 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and...
JUPITER, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and...
QUEENSBURY, N.Y., May 7, 2024 -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on May 14, 2024, at 8:30 AM Eastern Time...
WOBURN, MA / ACCESSWIRE / May 6, 2024 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will report financial results for the three months ended March 29, 2024 on...
Significantly Higher Overall Response Rate vs Meta-analysis of Historical Controls (36.3% vs. 5.5%) Other Efficacy Endpoints Include a 73.6% Disease Control Rate with a 7.7% Complete Response Rate NEW YORK, May 6, 2024 -- Delcath Systems, Inc. (Nasdaq: DCTH), an...
NEW YORK, May 3, 2024 -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously...
WOBURN, MA / ACCESSWIRE / May 3, 2024 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that the Board of Directors has met and certified that two criteria...
Reports record revenue of $17.6 million for the first quarter of 2024.Reports GAAP diluted EPS of $0.32 and non-GAAP diluted EPS of $0.36 for the first quarter of 2024.Reports first quarter of 2024 operating income of $4.7 million, an increase of 18.5 percent compared...
JUPITER, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and...
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., April 29, 2024 -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves...
WINTER SPRINGS, Fla., April 25, 2024 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the...
GARDNER, Mass., April 25, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the receipt of a follow-on production order totaling...
GARDNER, Mass., April 23, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that Dr. Joe Forkey, Chief Executive Officer, and Wayne...
CARMEL, Ind., April 23, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced the...
GARDNER, Mass., April 18, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced it has received a $720,000 follow on production order from...
SARASOTA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the establishment and acquisition of...
Today, we feature SOBR Safe, a company that designs and markets non-invasive devices, which detect the presence of alcohol in people using proprietary transdermal technology and algorithms. SOBR Safe is listed on the NASDAQ and trades under the symbol SOBR. Leading us...